Structured evidence table for Citrus Flavonoids Blood Pressure Meta-Analysis, generated from 2 reusable source documents in the Migaku knowledge base.
| topic | claim | evidence level | citation | source |
|---|---|---|---|---|
| Citrus Flavonoids Blood Pressure Meta-Analysis | Genetic factors, dietary habits, and lifestyle may influence individual responses to supplementation, including the bergamot flavanones naringin and naringenin, which are implicated in lipid modulation. | 2 | Yu X (2026) | Lipid Metabolism Modulation by a Flavonoid-Standardized <i>Citrus Bergamia</i> Extract in an Asian Population: Findings From a Double-Blind, Placebo-Controlled Clinical Trial. |
| Citrus Flavonoids Blood Pressure Meta-Analysis | The aim of this double-blind, placebo-controlled clinical trial (RCT) is to assess the effects of the supplementation for four months of a standardised bergamot extract at the dosage of 375 mg/day, providing 150 mg/day of flavonoids, on lipid parameters of 108 East Asian adults with LDL-Cholesterol (LDL-C) 100-159 mg/day, since to date, the RCTs have been conducted on Caucasian subjects only. | 2 | Yu X (2026) | Lipid Metabolism Modulation by a Flavonoid-Standardized <i>Citrus Bergamia</i> Extract in an Asian Population: Findings From a Double-Blind, Placebo-Controlled Clinical Trial. |
| Citrus Flavonoids Blood Pressure Meta-Analysis | The increasing burden is largely driven by metabolic risk factors such as hypertension, obesity, dyslipidemia, and impaired glucose regulation, reflecting the ongoing global rise in metabolic disorders []. | 3 | Doaei Saeid (2026) | Flavanone Intake and Cardiometabolic Outcomes: A Synthesis of Meta-Analytic Evidence from Cohort and Clinical Studies |
| Citrus Flavonoids Blood Pressure Meta-Analysis | Environmental and lifestyle factors, including diet quality and intake of bioactive dietary components, are increasingly recognized as major contributors to cardiometabolic risk []. | 3 | Doaei Saeid (2026) | Flavanone Intake and Cardiometabolic Outcomes: A Synthesis of Meta-Analytic Evidence from Cohort and Clinical Studies |
| Citrus Flavonoids Blood Pressure Meta-Analysis | These compounds may influence gene expression through epigenetic mechanisms and have been associated with the prevention of cardiometabolic diseases [,]. | 3 | Doaei Saeid (2026) | Flavanone Intake and Cardiometabolic Outcomes: A Synthesis of Meta-Analytic Evidence from Cohort and Clinical Studies |
| Citrus Flavonoids Blood Pressure Meta-Analysis | 1 2 3 4 Cardiometabolic diseases, including cardiovascular diseases (CVDs) and metabolic disorders are the leading cause of mortality worldwide []. | 3 | Doaei Saeid (2026) | Flavanone Intake and Cardiometabolic Outcomes: A Synthesis of Meta-Analytic Evidence from Cohort and Clinical Studies |
Source documents